| Hematology Uday.Deotare@lhsc.on.ca |
|||
 UDAY DEOTARE, MBBS, MD, Associate ProfessorDr. Deotare completed his undergraduate and postgraduate training in India as well as specialization in Hematology from the prestigious Christian Medical College, Vellore. He further harnessed his skills in the field of Bone marrow transplantation and made this his field of research and training. He subsequently completed Clinical Research Fellowship at Princess Margaret Cancer Center, Toronto in Leukemia and Bone Marrow Transplantation. During his 4 years at PMH, he was involved in various clinical trials, clinical research and developing new protocols in his area of interest of Graft versus Host Disease. He also worked as a Junior Faculty in his last 2 years of Fellowship and developed special interest in Quality innovation during this time and will be pursuing his Masters in the same. He is an Associate Professor at Schulich School of Medicine and Dentistry at Division of Hematology and Department of Medicine. He also has a cross appointment with Department of Oncology. He is an Assistant Director of the Blood and Marrow Transplant Program and Staff Physician in Hematology at LHSC. His research interests includes Graft versus Host Disease, post-transplant viral infections and Models of Care in Healthcare Quality. He is the member of the CBMTG CTN Group and Primary Investigator in major BMT Clinical trials. Keywords: Bone Marrow Transplant Graft versus Host Disease Quality Innovation Viral infections | |||
| Hematology Alan.Gob@lhsc.on.ca |
|||
 ALAN GOB, MSc, MD, FRCPC, Assistant ProfessorDr. Gob’s clinical interest is in benign and consultative hematology; his academic interest is in Quality Improvement. He is a member of several quality committees including LHSC’s Quality and Patient Safety Committee and is involved in several organizational quality improvement projects. He designs and delivers the content for the Department of Medicine’s postgraduate Quality Improvement Curriculum. | |||
| Hematology Cyrus.Hsia@lhsc.on.ca |
|||
 CYRUS HSIA, MD, FRCPC, HBSc, Associate Professor I completed by undergraduate degrees in Mathematics and Human Biology at the University of Toronto, my medical school training at the University of Western Ontario (Schulich School of Medicine & Dentistry), my residency in Internal Medicine and fellowship training in Hematology at UWO as well. Currently, I am an associate professor at Western University and associate medical director of the blood transfusion laboratory at the London Health Sciences Centre. My research interests are mainly in the field of transfusion medicine in the safe and appropriate utilization of blood and blood products as it relates to hematologic diseases. Specific clinical areas of interest include ITP, MDS, iron deficiency and overload. Keywords: Anemia Blood Blood products Iron Iron deficiency Iron overload ITP MDS Myelodysplasia Transfusion medicine | |||
| Hematology michael.kovacs@lhsc.on.ca |
|||
 MICHAEL KOVACS, MD, FRCPC, ProfessorBio sketch and keywords unavailable. | |||
| Hematology Selay.Lam@lhsc.on.ca |
|||
 SELAY LAM, MD, FRCPC, Assistant ProfessorDr. Selay Lam is a clinical hematologist at the London Health Sciences Centre with a cross-appointment at the London Regional Cancer Program. She is an Associate Professor of Medicine at The Schulich School of Medicine, Western University. Dr. Lam graduated from University of Ottawa Medical School in 2008, and then did her Internal Medicine and Hematology training at Western University. She joined the Division of Hematology at Western University in 2013. Her main clinical and research interests are in lymphoproliferative disorders and plasma cell dyscrasia. She is the Medical Director of the Hematology Disease Site Team at LRCP, and a member of the Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence Based Care. She is presently the local Principal Investigator for many lymphoma and myeloma clinical trials run through the Hematology Clinical Research Unit at London Regional Cancer Program. Dr. Lam is a leader in Medical Education at Schulich School of Medicine. She is the Undergraduate Medical Education Hematology Lead. She has also been Competency Based Medical Education Director for Internal Medicine and Hematology Residency Training Program at Western University since 2017. She is currently the Associate Program Director for the Postgraduate Training Program in Internal Medicine. Keywords: Amyloidosis Hodgkin Lymphoma Medical Education Multiple Myeloma Non-Hodgkin Lymphoma Plasma Cell Dyscrasias | |||
| Hematology alazo@uwo.ca |
|||
 ALEJANDRO LAZO LANGNER, MD, FRCPC, Professor, Chair, Division of HematologyAlejandro Lazo-Langner MD MSc FRCPC is an Associate Professor of Medicine, Oncology, and Epidemiology and Biostatistics at Western University where he is the Chair/Chief of the Division of Hematology. He is an Associate Scientist at Lawson Health Research Institute and an Adjunct Scientist at IC/ES Western. He holds an MD degree from Universidad La Salle School of Medicine in Mexico and an MSc in Clinical Epidemiology from the University of Ottawa. His research is focused on determinants of thromboembolic diseases, population-based studies, systematic reviews and meta-analysis, clinical trials, and risk-benefit analysis. Keywords: Epidemiological methods Meta-analysis Risk-benefit assessment Systematic reviews Venous thromboembolic disease | |||
| Hematology Martha.Louzada@lhsc.on.ca |
|||
 MARTHA LOUZADA, MD, FRCPC, BSc, MSc, Associate ProfessorDr. Martha Louzada, BSc, MD, MSc is a Brazilian-born Hematologist. She is an Assistant Professor of Medicine and a Hematology Consultant at the University of Western Ontario/ London Health Sciences Centre in London, Ontario, Canada, joining the Department of Medicine in July 2010. She also holds a Cross Appointment in Oncology through the London Regional Cancer Program. Dr. Louzada took her medical training in Rio de Janeiro - Brazil. Her entire academic career in Medicine has been marked by an ascending level of qualification and recognition, both nationally and internationally at each academic institution where she studied or worked. She received her undergraduate degree in Biology with a Bachelor’s degree in Genetics at Universidade Federal do Rio de Janeiro and obtained her medical degree from Souza Marques School of Medicine in December 1999, both with highest honors. After completing her Internal Medicine Residency Program at Santa Casa de Misericordia Hospital she did a 3-year Haematology Residency program at Instituto Nacional de Cancer (National Cancer Institute). This gave her a strong background in malignant Haematology and bone marrow transplantation. In 2006, she embarked on a new experience in North America coming to Ottawa, Canada, for a 3- year postdoctoral fellowship in Thrombosis along with a Masters in Epidemiology and Community Medicine Program at the University of Ottawa / Ottawa Hospital, Canada. It was in Ottawa that her research career started, under the supervision of internationally leading thrombosis researchers Drs. Phil Wells and Marc Rodger. In October 2009 she was awarded the Phil Wells Trainee Research Award at the University of Ottawa, recognizing Excellence in Haematology Research. She received her Masters in Epidemiology degree in January 2011. Keywords: Cancer Thrombosis | |||
| Hematology joy.mangel@lhsc.on.ca |
|||
 JOY MANGEL, MD, FRCPC, Associate Professor Dr. Joy Mangel is a clinical hematologist at the London Health Sciences Centre with a cross-appointment at the London Regional Cancer Program. She is an Associate Professor of Medicine at The Schulich School of Medicine, Western University. Dr. Mangel graduated from McGill Medical School in 1994, did her Internal Medicine and Hematology training at McGill University, and then did a 2 year research fellowship in the Advanced Therapeutic Program at the Toronto Sunnybrook Regional Cancer Centre specializing in clinical trials for lymphoma. She joined the Division of Hematology at Western University in 2003. Her main clinical and research interests include Hodgkin and non-Hodgkin lymphoma, and clinical trials for lymphoma. She is presently a local Principal Investigator for lymphoma and CLL clinical trials run through the Hematology Clinical Research Unit at London Regional Cancer Program. She sits on the Lymphoma Subcommittee for the National Cancer Institute of Canada Clinical Trials Group, and is a member of the Clinical Guidance Panel for the Pan-Canadian Oncology Drug Review (pCODR) Expert Review Committee. Dr. Mangel also has a special interest in medical education. She was the Program Director for the Western Postgraduate Training Program in Adult Hematology for 10 years. She is also passionate about physician wellness, and is presently the wellbeing lead for the Department of Medicine. Keywords: Hodgkin Lymphoma Non-Hodgkin Lymphoma | |||
| Hematology anargyros.xenocostas@lhsc.on.ca |
|||
 ANARGYROS XENCOSTAS, MD, FRCPC, Associate Professor
Dr. Anargyros Xenocostas is currently a Consultant in the Division of Hematology, Department of Medicine, at the London Health Sciences Centre, as well as an Assistant Professor of Medicine at the University of Western Ontario. He also holds a Cross Appointment as an Honourary Consultant in Hematology/Oncology at the London Regional Cancer Centre. Dr. Xenocostas obtained his Bachelor of Science in Honours Immunology and spent several years doing graduate studies at McGill University. The focus of these studies was the mechanisms responsible for the depression of primary B lymphocyte genesis in the bone marrow and subsequent immunosuppression during Graft versus Host reactions. He then went on to obtain his medical degree and complete his studies in Internal Medicine at McGill University. Dr. Xenocostas completed his Hematology Fellowship at the University of Toronto and pursued further subspecialty training in allogeneic bone marrow transplantation at the Princess Margaret Hospital. Current full-time clinical work includes the treatment of patients with hematologic malignancies and hemopoietic stem cell transplantation. Recent research projects have included looking at the effects of anemia during allogeneic hemopoietic stem cell transplantation and the creation of an Acute Myeloid Leukemia Cell Bank. A longstanding research interest has been the potential application of erythropoietin (EPO) as a neuroprotective and cardioprotective agent in collaboration with a number of basic researchers at UWO. Specific research projects have included examination of EPO-mediated effects on delayed vasospasm and the maintenance of cerebral blood flow after subarachnoid hemorrhage, the prevention of deleterious cardiac remodeling after acute myocardial infarction and the effects of anemia and transfusion during acute myocardial infarction. As well, the role of EPO in inflammation and maintenance of normal microcirculation are being examined in septic and hemorrhagic animal models. A number of potential clinical applications for EPO are being explored in Phase I/II trials Keywords: Erythropoietin Hemopoietic stem cell transplantation Leukemia (Acute) Tissue protection Translational research | |||
